A detailed history of Redmile Group, LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 552,506 shares of KROS stock, worth $30.9 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares
552,506
Previous 552,506 -0.0%
Holding current value
$30.9 Million
Previous $25.2 Million 27.07%
% of portfolio
2.1%
Previous 1.65%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$41.26 - $70.48 $22.8 Million - $38.9 Million
552,506 New
552,506 $36.6 Million

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.44B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.